Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3

Science

Volumn 275, Issue 5308, 1997, Pages 1930-1933

  Beals, Chan R ^a   Sheridan, Colleen M ^a   Turck, Christoph W ^a   Gardner, Phyllis ^a   Crabtree, Gerald R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMMONIUM SULFATE; ANTIBODY; CALCINEURIN; CALCIUM ION; CASEIN KINASE; CASEIN KINASE II; CD40 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOSPORIN; GLUTATHIONE TRANSFERASE; GROWTH FACTOR; HYBRID PROTEIN; INSULIN; INTERLEUKIN 2; INTERLEUKIN 4; IONOMYCIN; LIGAND; LITHIUM; PHOSPHOPEPTIDE; PHOSPHORUS 32; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SERINE; TACROLIMUS; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; DEPHOSPHORYLATION; ENZYME ACTIVITY; GENE; IMMUNE RESPONSE; IMMUNOBLOTTING; PHOSPHORYLATION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCINEURIN; CALCIUM; CALMODULIN-BINDING PROTEINS; CELL NUCLEUS; CLONING, MOLECULAR; COS CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA-BINDING PROTEINS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HUMANS; MOLECULAR SEQUENCE DATA; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; RATS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0030890234     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.275.5308.1930     Document Type: Article

References (41)

1. J.-P. Shaw et al., Science 241, 202 (1988); P. G. McCaffrey et al., ibid. 262, 750 (1993); S. N. Ho et al., J. Biol. Chem. 270, 19898 (1995); T. Hoey, Y.-L. Sun, K. Williamson, X. Xu, Immunity 2, 461 (1995).
2. J.-P. Shaw et al., Science 241, 202 (1988); P. G. McCaffrey et al., ibid. 262, 750 (1993); S. N. Ho et al., J. Biol. Chem. 270, 19898 (1995); T. Hoey, Y.-L. Sun, K. Williamson, X. Xu, Immunity 2, 461 (1995).
3. J.-P. Shaw et al., Science 241, 202 (1988); P. G. McCaffrey et al., ibid. 262, 750 (1993); S. N. Ho et al., J. Biol. Chem. 270, 19898 (1995); T. Hoey, Y.-L. Sun, K. Williamson, X. Xu, Immunity 2, 461 (1995).
4. J.-P. Shaw et al., Science 241, 202 (1988); P. G. McCaffrey et al., ibid. 262, 750 (1993); S. N. Ho et al., J. Biol. Chem. 270, 19898 (1995); T. Hoey, Y.-L. Sun, K. Williamson, X. Xu, Immunity 2, 461 (1995).
5. J. P. Northrop et al., Nature 369, 497 (1994).
6. D. B. Durand et al., Mol. Cell. Biol. 8, 1715 (1988); P. N. Cockerill et al., ibid. 15, 2071 (1995); S. Chuvpilo et al., Nucleic Acids Res. 21, 5694 (1993); J. W. Rooney, T. Hoey, L. H. Glimcher, Immunity 2, 473 (1995); A. E. Goldfeld, P. G. McCaffrey, J. L. Strominger, A. Rao, J. Exp. Med. 178, 1365 (1993).
7. D. B. Durand et al., Mol. Cell. Biol. 8, 1715 (1988); P. N. Cockerill et al., ibid. 15, 2071 (1995); S. Chuvpilo et al., Nucleic Acids Res. 21, 5694 (1993); J. W. Rooney, T. Hoey, L. H. Glimcher, Immunity 2, 473 (1995); A. E. Goldfeld, P. G. McCaffrey, J. L. Strominger, A. Rao, J. Exp. Med. 178, 1365 (1993).
8. D. B. Durand et al., Mol. Cell. Biol. 8, 1715 (1988); P. N. Cockerill et al., ibid. 15, 2071 (1995); S. Chuvpilo et al., Nucleic Acids Res. 21, 5694 (1993); J. W. Rooney, T. Hoey, L. H. Glimcher, Immunity 2, 473 (1995); A. E. Goldfeld, P. G. McCaffrey, J. L. Strominger, A. Rao, J. Exp. Med. 178, 1365 (1993).
9. D. B. Durand et al., Mol. Cell. Biol. 8, 1715 (1988); P. N. Cockerill et al., ibid. 15, 2071 (1995); S. Chuvpilo et al., Nucleic Acids Res. 21, 5694 (1993); J. W. Rooney, T. Hoey, L. H. Glimcher, Immunity 2, 473 (1995); A. E. Goldfeld, P. G. McCaffrey, J. L. Strominger, A. Rao, J. Exp. Med. 178, 1365 (1993).
10. D. B. Durand et al., Mol. Cell. Biol. 8, 1715 (1988); P. N. Cockerill et al., ibid. 15, 2071 (1995); S. Chuvpilo et al., Nucleic Acids Res. 21, 5694 (1993); J. W. Rooney, T. Hoey, L. H. Glimcher, Immunity 2, 473 (1995); A. E. Goldfeld, P. G. McCaffrey, J. L. Strominger, A. Rao, J. Exp. Med. 178, 1365 (1993).
11. W. M. Flanagan, B. Corthesy, R. J. Bram, G. R. Crabtree, Nature 352, 803 (1991); L. A. Timmerman, N. A. Clipstone, S. N. Ho, J. P. Northrop, G. R. Crabtree, ibid. 383, 837 (1996).
12. W. M. Flanagan, B. Corthesy, R. J. Bram, G. R. Crabtree, Nature 352, 803 (1991); L. A. Timmerman, N. A. Clipstone, S. N. Ho, J. P. Northrop, G. R. Crabtree, ibid. 383, 837 (1996).
13. J. Liu et al., Cell 66, 807 (1991).
14. C. R. Beals, N. A. Clipstone, S. N. Ho, G. R. Crabtree, in preparation. To distinguish the four genes that encode the four cytoplasmic, cyclosporin-sensitive, calcineurin-dependent, constitutive subunits of NF-AT1 (1) from the nuclear, inducible subunits (NF-ATn) [W. M. Flanagan et al., in (4)], the Genome Nomenclature Committee has designated the four genes encoding the NF-AT subunits as NF-ATc1 (NF-ATc), NF-ATc2 (NF-ATp), NF-ATc3 (NF-ATx or NF-AT4), and NF-ATc4 (NF-AT3).
15. K. Hughes, B. J. Pulverer, P. Theocharous, J. R. Woodgett, Eur. J. Biochem. 203, 305 (1991).
16. C. J. Fiol et al., J. Biol. Chem. 269, 32187 (1994).
17. G. I. Welsh, S. Miyamoto, N. T. Price, B. Safer, C. G. Proud, ibid. 271, 11410 (1996).
18. C. R. Beals and G. R. Crabtree, unpublished data.
19. GSK-3 immunodepletion does not effect the phosphorylation of the unprimed NF-AT substrate because under conditions of substrate excess, only a small percentage of substrate becomes primed and hence available for subsequent phosphorylation by GSK-3. We know that enzyme is limiting in these assays because there is no detectable alteration of the mobility of the substrate upon Coomassie staining, which would reflect phosphorylation. We can clearly detect such mobility differences when they occur as seen in Fig. 3A.
20. F. Shibasaki, E. R. Price, D. Milan, F. McKeon, Nature 382, 370 (1996); Luo et al., Proc. Natl. Acad. Sci. U.S.A. 93, 8907 (1996).
21. F. Shibasaki, E. R. Price, D. Milan, F. McKeon, Nature 382, 370 (1996); C. Luo et al., Proc. Natl. Acad. Sci. U.S.A. 93, 8907 (1996).
22. J. R. Woodgett, in Methods in Enzymology, T. Hunter and B. M. Sefton, Eds, (Academic Press, San Diego, CA, 1991), vol. 200, p. 564.
23. E. Nikolakaki, P. J. Coffer, R. Hemelsoet, J. R. Woodgett, L. H. Defize, Oncogene 8, 833 (1993).
24. N. A. Clipstone and G. R. Crabtree, Nature 357, 695 (1992).
25. X. He, J. P. Saint-Jeannet, J. R. Woodgett, H. E. Varmus, I. B. Dawid, ibid. 374, 617 (1995).
26. J. Liu et al., Cell 66, 807 (1991).
27. D. Mary, C. Aussel, B. Ferrua, M. Fehlmann, J. Immunol. 139, 1179 (1987).
28. D. A. E. Cross, D. R. Alessi, P. Cohen, M. Andjelkovich, B. A. Hemmings, Nature 378, 785 (1995).
29. H. Eldar-Finkelman, R. Seger, J. R. Vandenheede, E. G. Krebs, J. Biol. Chem. 270, 987 (1995).
30. P. S. Klein and D. A. Melton, Proc. Natl. Acad. Sci. U.S.A. 93, 8455 (1996).
31. M. Bourouis et al., EMBO J. 9, 2877 (1990); E. Siegfried, L. A. Perkins, T. M. Capaci, N. Perrimon, Nature 345, 825 (1990).
32. M. Bourouis et al., EMBO J. 9, 2877 (1990); E. Siegfried, L. A. Perkins, T. M. Capaci, N. Perrimon, Nature 345, 825 (1990).
33. D. Cook et al., EMBO J. 15, 4526 (1996); V. Stambolic, L. Ruel, J. R. Woodgett, Curr. Biol. 6, 1664 (1996).
34. D. Cook et al., EMBO J. 15, 4526 (1996); V. Stambolic, L. Ruel, J. R. Woodgett, Curr. Biol. 6, 1664 (1996).
35. 4 fractionation and separation on phosphocellulose, eluting with 200 mM NaCl. These active fractions were pooled and further purified on a Mono-S column (7).
36. 4. Kinase reactions were terminated by washing the agarose beads twice with 1 ml of TEN [50 mM tris (pH 7.5), 1 mM EDTA, 150 mM NaCI, and 0.5% NP-40] to remove phosphorylated cellular proteins, fractionated on SDS-PAGE, autoradiographed, and stained with Coomassie to ensure that the substrate was not degraded.
37. Immunodepletion of GSK-3 activity in 110 μg of whole brain extract was done in 200 μl of TEN, 1 mM DTT, and protease and phosphatase inhibitors (24) with 3 μg of anti-GSK-3a (sheep polyclonal, Upstate Biotechnology), anti-GSK-3β [immunoglobulin G1 (IgG1) monoclonal, Transduction Labs], or both, and 20 μl of protein G-Sepharose at 40°C for 4 hours. The IgGI mouse monoclonal antibody (mAb) M2 (Kodak), sheep polyclonal anti-HIVp17 (NIH), or both were used as control antibodies. The NF-AT kinase assay used 2.5 μl of the supernatant (1.2 μg of protein) (23).
38. 32P]orthophosphate (1 mCi/ml) for 6 hours and immunoprecipitated with the hemagglutinin (HA) mAb 12CA5, transferred to polyvinylidene difluoride membrane, and digested with trypsin. Oxidized peptides (1000 cpm) were separated by electrophoresis on cellulose at pH 1.9 for 30 min at 1000 V and then chromatographed in the second dimension using butanol-acetic acid-pyridine solvent [W. J. Boyle, P. Van der Geer, T. Hunter, Methods Enzymol. 201, 110 (1991)].
39. Human GSK-3β cDNA (76) and ERK cDNA were cloned into pBJ-5. Drosophila CKII cDNA was polymerase chain reaction-amplified and cloned into pBJ-5. Murine PKA cDNA and an activated form of PKC-β were cloned into pSRα. The calcineurin A and B expression constructs (75), CaMkII constructs [M. Srinivasan, C. F. Edman, H. Schulman, J. Cell Biol. 126, 839 (1994)], COS cell NF-AT translocation assay (6), and Jurkat-T antigen cell transcription reporter assays (2) were as described.
40. D. M. Spencer, T. J. Wandless, S. L. Schreiber, G. R. Crabtree, Science 262, 1019 (1993).
41. We thank M. Karin for helpful discussions and sharing unpublished information.